Using In Silico Methods to Identify Protein Tyrosine Kinase A (PtkA) Homolog in Non-Tuberculous Mycobacteria (NTM) by Swati Jaiswal, Sanjay Kumar

Subjects: Get full text

Update on IJTLD OPEN: the future is open by H.D. Blackbourn, G.B. Migliori

Subjects: “…tuberculosis…”
Get full text

The intersection of TB and health financing: defining needs and opportunities by W.A. Wells, S. Waseem, S. Scheening

Subjects: “…tuberculosis…”
Get full text

Challenges and Barriers Faced by People with TB and Healthcare Workers Providing TB Care and Management – A Qualitative Study by S. Suseendar, Akhil Dhanesh Goel, T. Pritish Baskaran, V. R. Rehana, Pankaj Bhardwaj, Manoj Kumar Gupta, S. Srikanth, Suman Saurabh

Subjects: Get full text

Five lessons from a mid-level health manager intervention to increase uptake of tuberculosis prevention therapy in Uganda: ‘it is a completely different thing to implement what you know.’ by Jason Johnson-Peretz, Canice Christian, Cecilia Akatukwasa, Fred Atwine, Elijah Kakande, Moses R. Kamya, Diane V. Havlir, Carol S. Camlin, Gabriel Chamie

Subjects: Get full text

TB-related catastrophic costs and associated factors for patients in Ethiopia by Z.G. Dememew, A.A. Deribew, D.G. Datiko, K. Melkieneh, T.G. Laloto, S. Negash, C. Gilmartin, M. Melese, P.G. Suarez

Subjects: “…tuberculosis…”
Get full text

Tuberculose na população privada de liberdade by Pablo Cristiano de Souza, Rodrigo de Macedo Couto, Alec Brian Lacerda, Pãmela Rodrigues de Souza Silva, Omar Ariel Espinosa, Jaqueline Costa Lima

Subjects: Get full text

Additive Effects of Glutathione in Improving Antibiotic Efficacy in HIV–<i>M.tb</i> Co-Infection in the Central Nervous System: A Systematic Review by Leena Nabipur, Michael Mouawad, Vishwanath Venketaraman

Subjects: Get full text

Comprehensive care for people affected by TB: addressing TB-associated disabilities by M. Calvi, D. Boccia, E. Jaramillo, F. Mavhunga, J. Reeder, T. Kasaeva

Subjects: Get full text

Determinant of catastrophic costs associated with treatment for rifampicin-resistant TB in households in the Republic of Moldova by A. Ciobanu, V. Plesca, S. Doltu, M. Manea, L. Domente, A. Dadu

Subjects: Get full text

Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in Pakistan by M.A. Khan, A. Ismail, A. Ghafoor, N. Khan, N. Muzaffar, F. Zafar, A. Gupta, S. Foraida, S. Juneja, R. Fatima, A.W. Khan, S. Shahid, M.A. Khan

Subjects: “…drug-resistant tuberculosis…”
Get full text

Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022 by Phyu Win Ei, Mi Mi Htwe, Myat Htut Nyunt, Aye Su Mon, Zaw Myint, Wint Wint Nyunt, Su Mon Win, Sandar Aung, Wai Myat Thwe, Wah Wah Aung

“…Objective: Detecting rifampicin (RIF) resistance is crucial in selecting tuberculosis (TB) treatment. Recently, several studies reported that I491F and V170F rpoB mutations were found with a varying prevalence. …”
Get full text

Guttiferone K Exerts the Anti-inflammatory Effect on Mycobacterium Tuberculosis- (H37Ra-) Infected Macrophages by Targeting the TLR/IRAK-1 Mediated Akt and NF-κB Pathway by Qingwen Zhang, Jinxia Sun, Yan Fu, Weigang He, Yinhong Li, Hongsheng Tan, Hongxi Xu, Xin Jiang

“…Mycobacterium tuberculosis (Mtb) remains a great threat to global health, killing more people than any other single infectious agent and causing uncontrollable inflammation in the host. …”
Get full text

The Emergence of Extensively Drug-Resistant Tuberculosis (TB): TB/HIV Coinfection, Multidrug-Resistant TB and the Resulting Public Health Threat from Extensively Drug-Resistant TB, Globally and in Canada by Paul E Alexander, Prithwish De

“…Resistance to anti-tuberculosis (TB) drugs continues to present a major challenge to global public health. …”
Get full text

Codeveloping a community-based, peer-led psychosocial support intervention to reduce stigma and depression among people with tuberculosis and their households in Indonesia: a mixed-methods participatory action study by Ahmad Fuady, Mariska Anindhita, Matsna Hanifah, Arieska Malia Novia Putri, Artasya Karnasih, Feranindhya Agiananda, Finny Fitry Yani, Marinda Asiah Nuril Haya, Trevino Aristaskus Pakasi, Tom Wingfield

“…Abstract Evidence relating to peer support and community-based psychological and social (psychosocial) interventions to reduce stigma and depression among people with tuberculosis (TB) and their households is limited. This study aimed to engage with multisectoral stakeholders in Indonesia to co-develop a peer-led, community-based psychosocial intervention that is replicable, acceptable, and sustainable. …”
Get full text

TB and poverty: the effect of rifampicin-resistant TB on household income by A. Ciobanu, V. Plesca, S. Doltu, M. Manea, L. Domente, A. Dadu

Subjects: “…rifampicin-resistant tuberculosis…”
Get full text

Synthesis, <i>In Vitro</i> and <i>In Silico</i> Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents by Wael Shehta, Norah A. Alsaiari, Basant Farag, Marwa M. Abdel-Aziz, Shaker Youssif, Sherin M Elfeky, Samar El-Kalyoubi, Nermine A. Osman

Subjects: “…Mycobacterium tuberculosis…”
Get full text

Detection of other pathologies when utilising computer-assisted digital solutions for TB screening by J. Sebastian, I.D. Olaru, A. Giannakis, M. Arentz, S.V. Kik, M. Ruhwald, S. Linsen, G. Günther, P. Wolf, F.J. Herth, T. Weber, C.M. Denkinger

Subjects: “…tuberculosis screening…”
Get full text

Perceptions and clinical practices associated with post-TB health and well-being in the Netherlands by I. Spruijt, A. Verhage, F. Procee, N. Vrubleuskaya, C. Mulder, O. Akkerman

Subjects: “…tuberculosis…”
Get full text

Network pharmacology and in silico investigation into the therapeutic potential of phytoconstituents of Peucedanum ostruthium as anti-tubercular agents by Neeru Bhanwala, Raunak Katiyar, Sumit Kumar, Ashok K. Datusalia, Gopal L. Khatik

Subjects: “…Mycobacterium tuberculosis…”
Get full text